Docstoc

Preliminary agenda

Document Sample
Preliminary agenda Powered By Docstoc
					                              Preliminary Agenda

10.30 – 12.30             INCA discussion.
                          Swedish regional coordinators

                      Pre-clinical MDS Research Symposium
                 Thursday 18.11.2010, Hotel Hellsten, Stockholm
           For brief presentations; 10 minutes talk (+ 10 minutes discussion)

12.30 - 13.30             Lunch (only for participants in special meetings)
13.30 - 13.50             Review: Histone acetylation, HDACs and HATs in myeloid
                          malignancies.
                          Johanna Ungerstedt, Karolinska Institutet
13.50 – 14.10             Impact of freezing/thawing on histone acetylation pattern.
                          Magnus Tobiasson, Karolinska Institutet
14.10 – 14.30             Complex effects of azacytidine on primary bone marrow cells.
                          Michael Grövdal, Karolinska Institutet
14.30 - 14.50             Methylation of a novel candidate tumor suppressor vtRNA predicts
                          poor prognosis in high-risk MDS/AML.
                          Marianne Treppendal, Copenhagen
14.50 - 15.10             DNA Methylation In Normal Karyotype Acute Myeloid Leukemia.
                          Stefan Deneberg, Karolinska Institutet
15.10 – 15.40             Coffee break
15.40 - 16.10             Therapeutic targeting and clinical surveillance of del(5q) MDS
                          stem and progenitor cells.
                          Oni Chowdhury, Oxford
16.10 - 16.30             Cellular and molecular characterisation of del(5q) MDS stem and
                          progenitor cells in man and mouse.
                          Petter Woll, Oxford
16.30 - 16.50             Lenalidomide: SPARCs flying in the niche.
                          Christian Scharenberg, Karolinska Institutet
16.50 – 17.10             NK cells in MDS.
                          Kalle Malmberg
17.10 - 17.30             ABCB7 – a final pathway to sideroblast formation, but what are
                          the upstream events?
                          Maryam Nikpour, Karolinska Institutet
17.30 - 18.10             Mitochondrial DNA variations in acute myeloid leukaemia.
                          Trine Silkjaer
18.30                     Drinks and dinner
                          Preliminary Agenda

                    Work Meeting in the Nordic MDS Group
                Friday 19.11.2010, Hotel Hellsten, Stockholm


09.00 - 9.30     Get together and Coffee
9.30 - 10.00     NMDSG08A.
                 Magnus Tobiasson
10.00 - 11.00    NMDSG10B. Update and final protocol discussion.
                 Bengt Rasmussen, Bertil Uggla and Lars Möllgård
11.00 - 12.00    NMDSG10A. Update and final protocol discussion.
                 Tobias Svensson and Honar Cherif
12.00 - 12.30    5q- registry (NMDSG09A) and other 5q studies.
                 Leonie Saft, Eva Hellström-Lindberg
12.30 - 13.15    Lunch
13.15 - 14.00    NMDSG activities including Nordic Guidelines and Nordic
                 Biobank.
                 Eva Hellström-Lindberg, Kirsten Gronbaek
14.00 - 14.30    SCT – discussion about surveillance and Biobank protocol
                 All
14.30 - 15.00    EU MDS registry. Update and report.
                 Eva Hellström-Lindberg, Lotta Hartler Ahlin,
                 Mette Skov Holm
15.00 - 15.15    Coffee
15.15 - 16.00    INCA discussion.
                 Lars Nilsson, Elisabeth Ejerblad

				
DOCUMENT INFO